Sökning: "health care political science"
Visar resultat 1 - 5 av 42 avhandlingar innehållade orden health care political science.
1. Confronting Value Strain : Press Coverage of Health Care Reform in Sweden and the United States
Sammanfattning : This dissertation examines the journalistic discourse surrounding health care reform debates in Sweden and the US in the early 1990's. It found that in both countries, the challenging value (i.e. LÄS MER
2. Rättvisa och demokrati : Om prioriteringar i sjukvården : [rationing health care resources]
Sammanfattning : The dissertation focuses on the growing problem of allocating scarce health care resources inmodem societies. There are several factors which have contributed to the aggravation of thisproblem. The most important is the success. LÄS MER
3. The Governance Gap : Central–local steering & mental health reform in Britain and Sweden
Sammanfattning : Why do governments choose certain types of governance strategies to steer the lower level agencies such as municipalities, health services and other welfare agencies? This is a problem facing many governments in the era of public management reforms, where policies are decided at national level while service responsibilities are decentralised and implemented by lower levels. Thus the main mechanism for governments to influence the implementation of these national reforms is through its choice of strategies and instruments to fill the governance gap between national policy-making and local government. LÄS MER
4. Ideas and Policy Convergence : Health Care Reforms in the Netherlands and Sweden in the 1990s
Sammanfattning : .... LÄS MER
5. Healthcare Priority Setting and Rare Diseases : What Matters When Reimbursing Orphan Drugs
Sammanfattning : The rarity of a disease can give rise to challenges that differ from conventional diseases. For example, rarity hampers research and development of new drugs, and patients with severe, rare diseases have limited access to qualified treatments. When drugs are available, clinical evidence has higher uncertainty and the drugs can be very expensive. LÄS MER
